Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
- 20 March 2008
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 30 (11) , 1818-1824
- https://doi.org/10.1016/j.neurobiolaging.2008.02.002
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- In VitroCharacterization of Pittsburgh Compound-B Binding to Lewy BodiesJournal of Neuroscience, 2007
- P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse modelJournal of Clinical Investigation, 2005
- Potential role of ABC transporters as a detoxification system at the blood?CSF barrierAdvanced Drug Delivery Reviews, 2004
- Long-Term Accumulation of Amyloid-β, β-Secretase, Presenilin-1, and Caspase-3 in Damaged Axons Following Brain TraumaThe American Journal of Pathology, 2004
- Quantitative assessment of P-glycoprotein function in the rat blood–brain barrier by distribution volume of [11C]verapamil measured with PETNeuroImage, 2003
- The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?The Lancet Neurology, 2003
- Polymorphism in the P-glycoprotein drug transporter MDR1 genePharmacogenetics, 2003
- Expression polymorphism of the blood???brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's diseasePharmacogenetics, 2002
- Isolation of Endothelial Cells from Brain, Lung, and Kidney: Expression of the Multidrug Resistance P-Glycoprotein IsoformsBiochemical and Biophysical Research Communications, 2001
- Comparing Functional (PET) Images: The Assessment of Significant ChangeJournal of Cerebral Blood Flow & Metabolism, 1991